TOP TIERMARKET NEWSWIRE

News & sentiment

PERSONALIS INC (PSNL) — News & AI sentiment

PERSONALIS INC (PSNL) news roundup. 1 story in the past week, 14 over 30 days. Average 30-day sentiment is 57.9/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $5.1M — net selling of $5.1M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

1

avg sentiment 50/100

30d stories

14

avg sentiment 57.9/100

Insider net (90d)

$5.1M

0 buys · 5 sells

Congress (90d)

0

0 buys · 0 sells

PSNL news in the last 24 hours, 7 days, 30 days and 90 days

How much PSNL coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	PSNL stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	1	50/100	PSNL headlines →
Last 30 days	14	57.9/100	PSNL headlines →
Last 90 days	52	57.3/100	PSNL headlines →

Latest stories on PSNL

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

GlobeNewswire50 · neutralgeneral

4d ago

The Cancer Vaccine Gold Rush Has Begun. So Has the Race for Picks and Shovels.

WSJ67 · bullishproduct/pr

Sep 4

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX)

GlobeNewswire50 · neutralgeneral

Sep 3

Abrdn Life Sciences Investors Q2 2026 Commentary

Seeking Alpha64 · neutralproduct/pr

Aug 30

Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?

Yahoo Top67 · bullishproduct/pr

Aug 27

PSNL Chart for Personalis Stock

Barchart50 · neutralgeneral

Aug 27

Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next.

Yahoo Top63 · neutralgeneral

Aug 26

Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next.

Barchart63 · neutralgeneral

Aug 26

abrdn Healthcare Investors Q2 2026 Commentary

Seeking Alpha63 · neutralproduct/pr

Aug 25

Personalis falls amid a downgrade as a competitive bid appears unlikely

Seeking Alpha34 · bearishanalyst

Aug 24

Personalis downgraded to Hold from Buy at Craig-Hallum

The Fly53 · neutralanalyst

Aug 24

Personalis secures new Million Veteran Program task order

TipRanks63 · neutralproduct/pr

Aug 20

Personalis, Inc. (PSNL) files 8-K

SEC 8-K50 · neutralgeneral

Aug 20

TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial

Stocktwits News73 · bullishproduct/pr

Aug 19

Personalis, Inc. (PSNL) files 8-K

SEC 8-K50 · neutralgeneral

Aug 4

Personalis Reports Second Quarter Results and Recent Highlights

StockTitan63 · neutralearnings

Aug 4

Tempus Delivers Standout Q2 with 22% Revenue Growth and $200M in New Data Licensing Deals July 31, 2026

MarketChameleon73 · bullishearnings

Jul 31

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--LXP, BLFS, PSNL, and FNWD

PR Newswire50 · neutralgeneral

Jul 29

Tempus makes $1.5B bet to corner cancer-test market

The Street67 · bullishm&a

Jul 22

Personalis: Tempus Bought The Best Part Of The Story

Seeking Alpha48 · neutralm&a

Jul 21

Tempus AI Acquires Personalis: Why Both Stocks Are A Buy Now

Seeking Alpha67 · bullishm&a

Jul 21

Tempus AI is acquiring cancer-monitoring firm Personalis in a $1.5 billion stock deal

Quartz63 · neutralm&a

Jul 21

Tempus AI acquires cancer-monitoring firm Personalis for $1.5 billion

Yahoo Finance63 · neutralm&a

Jul 21

Tempus AI acquires Personalis in $1.5bn precision oncology-focused deal

Yahoo Top63 · neutralm&a

Jul 21

Personalis, Inc. (PSNL) M&A Call Transcript

Seeking Alpha50 · neutralm&a

Jul 21

Open PSNL in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →